Inhibition of Histone Deacetylation and DNA Methylation Improves Gene Expression Mediated by the Adeno-Associated Virus/Phage in Cancer Cells

Clathrin-mediated Endocytosis and Subsequent Endo-Lysosomal Trafficking of Adeno-associated Virus/Phage

(2012) Charlotte A. Stoneham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor Regression

(2012) A. Kia et al.   MOLECULAR CANCER THERAPEUTICS

Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage

(2012) Justyna M. Przystal et al.   Molecular Oncology

Effect of trichostatin A and 5-Aza-2′-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells

(2011) Qingran Kong et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

(2009) Evanthia Galanis et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis

(2009) P. Baumeister et al.   MOLECULAR CANCER THERAPEUTICS

A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer

(2009) M. Trepel et al.   MOLECULAR CANCER THERAPEUTICS

Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature

(2009) Melissa C. Paoloni et al.   PLoS One

Tumor vasculature-targeted delivery of tumor necrosis factor-α*

(2008) Anita Tandle et al.   CANCER

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

(2008) T. H. Luu et al.   CLINICAL CANCER RESEARCH

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

(2008) Susan C. Modesitt et al.   GYNECOLOGIC ONCOLOGY

Establishment of Murine Cytomegalovirus Latency In Vivo Is Associated with Changes in Histone Modifications and Recruitment of Transcriptional Repressors to the Major Immediate-Early Promoter

(2008) X.-f. Liu et al.   JOURNAL OF VIROLOGY

A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging

(2008) A. Hajitou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA